In it perhaps not entirely unexpected that the methylation of FGFR2 was found markedly altered in advanced NAFLD, with 23 CpG sites hypomethylated, promoting its overexpression and the establishment of an inflammatory and pro-fibrotic niche (75). This evidence concerns the gene FGFR2 and metabolic dysfunction-associated steatotic liver disease.